Wake Forest Cancer Center
Cancer Center
Analytical devices, like the ProofMed-CH™ V1.0 Scanner, help to assure patients and their healthcare team that their chemotherapy doses are properly formulated and free of impurities.
About Rametrix Technologies, Inc. And What We Do
A Tradition Of Excellence
We analyze liquids and develop actionable information, based on the molecular composition of the liquid. Our focus on molecular urinalysis has provided screening tools for important diseases, such as diabetes, chronic kidney disease, and bladder cancer.
Background
Starting with urinary tract diseases, we will empower doctors and patients to make critical health care decisions through early, accurate, chronic disease screening & detection in an affordable and efficient manner.
Technology
Our foundation is built on analytical devices and Artificial Intelligence (AI)/Machine Learning.
Results
- Ability to detect, stage & monitor Chronic and Diabetic Kidney Disease
- Detect, stage and monitor Bladder Cancer
- Detect, stage, and monitor COVID19
- Monitor effectiveness of hemodialysis in real-time
our mission
We will develop and use our cutting-edge, affordable technologies to improve human and animal health, leading to a better quality of life for all.
WE ARE RAMETRIX® TECHNOLOGIES, Inc.
Every molecular fingerprint matters!
WHY PEOPLE CHOOSE US
Thousands of specimens in reference database
Results in
< 15 minutes
Highly Accurate >90% sensitivity/specificity
Direct cost
< $1/analysis
Rametrix Technologies Brand Story
Our Customers
WHY PEOPLE CHOOSE US
All
Cancer Center
Transplant
Hospitals
Dialysis
Chemotherapy
Technician
Impurities
Organ Transplantation Monitoring
Transplant
Rametrix® Technologies, Inc. computational technology is being used to determine if organ transplants, such as kidneys, are functional in the critical days and weeks following implantation.
Carilion
Hospitals
Ongoing studies of hospitalized COVID19 patients, using Rametrix® Molecular Urinalysis, helps healthcare providers detect and intervene if potentially significant kidney failure develops.
Dialysis Machine in Operation
Dialysis
The Rametrix DialySensor V2.0 will be a key medical device for delivering precision hemodialysis and improving patient outcomes and quality of life.”
Chemotherapy
Chemotherapy
The newly developed ProofMed-CH V1.0 Scanner will be used to determine if cancer chemotherapy doses are correctly and safely formulated before administered to critically-ill patients.
Dr./Technician Looking at Urine Sample
Technician
Extensive studies of thousands of urine samples by Rametrix® Technologies, Inc. scientists and engineers, in collaboration with collaborating physicians and medical centers, have shown that serious health problems, like chronic kidney disease, can be quickly detected with Rametrix® Technologies, Inc. Molecular Urinalysis technology.
Mother Holding Infant Feeding from Bottle
Impurities
Rametrix® Technologies, Inc. scientists and engineers are responding to recent concerns over contaminated baby formula by developing procedures to detect impurities quickly – during manufacturing.
Why People Choose Us
At Rametrix® Technologies, Inc. it is the expertise and enthusiasm of our Team that empowers us to define and solve even the most difficult health and analytical problems.
WE ARE RAMETRIX® Technologies, Inc.
Every molecular fingerprint matters!
Latest news
Breakthrough test for detection of cancer in dogs announced
Rametrix Technologies, Inc., announced today that they have developed a urine-based…
Diabetic Kidney Disease Detection
Analysis of urine Raman spectra differences from patients with diabetes mellitus…
COVID-19 Hospitalized Patient Study
A study of 100 hospitalized COVID19 patient urine samples has shown…